Cambridge, MA, United States of America

Nasir Khan

This inventor holds 1 USPTO granted patent. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nasir Khan. Retrieved from https://idiyas.com/inventor/nasir-khan-cbj1x4eg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nasir Khan: Innovator in Antibody Compositions

Introduction

Nasir Khan is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions. His innovative work has led to the granting of a patent, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Nasir Khan holds a patent for "FCRN Antibody Compositions." This patent represents a crucial advancement in the understanding and application of antibody therapies, which can have a profound impact on treating various diseases.

Career Highlights

Khan is currently employed at Momenta Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development projects. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Throughout his career, Nasir Khan has worked alongside notable colleagues, including Michael Shifrin and Aneta Liwosz. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new therapeutic solutions.

Conclusion

Nasir Khan's work in antibody compositions exemplifies the spirit of innovation in biotechnology. His contributions not only advance scientific knowledge but also hold the potential to improve patient outcomes in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…